Palvella Therapeutics
PVLA
142.85
-2.92
-2.00%
Palvella Therapeutics
US · PVLA
#2822 by market cap
Listed 1970
142.85
-2.92
-2.00%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Palvella Therapeutics
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.
- Founded
- 2015
- CEO
- Mr. Wesley H. Kaupinen
- Employees
- 29
- Headquarters
- Wayne, Pennsylvania, United States of America
- Fiscal year end
- 12-31
- Website
- palvellatx.com
Company profile
- Exchange
- US
- Symbol
- PVLA
- Market-cap rank
- #2822
- Listing date
- 1970-01-01
- Market cap
- 2.09B
- Float cap
- 1.57B
- Shares out
- 14.62M
- Float shares
- 11.01M
Sectors & themes
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Palvella Therapeutics discussion 0 comments